Figure 2.
(a) Forest plots for the comparisons of serum endostatin levels between gastric cancer patients and healthy controls. (b) Sensitivity analyses for the comparisons of serum endostatin levels between gastric cancer patients and healthy controls. (c) Publication bias on the differences of serum endostatin levels between gastric cancer patients and healthy controls.